Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$644,826
-$121,119 QoQ
Shares Held
25,071
-37.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 290 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,264 across 414 Biotechnology names. DNLI ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,826 | 25,071 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $765,945 | 39,893 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $255,855 | 15,497 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,834,165 | 264,061 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $266,957 | 19,082 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $118,480 | 8,715 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $324,918 | 15,943 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $804,716 | 27,625 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $194,258 | 8,366 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,479,594 | 72,105 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $4,112,658 | 191,643 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,359,100 | 162,826 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,171,793 | 107,482 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,181,178 | 138,072 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,604,303 | 57,688 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,331,982 | 108,569 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $657,230 | 22,332 | Shares | Defined | 2022-08-12 | |
| 2021-12-31 | $878,575 | 19,699 | Shares | Defined | 2022-02-09 | |
| 2021-06-30 | $474,405 | 6,048 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $622,504 | 10,902 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $828,888 | 9,896 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $533,938 | 14,902 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $159,563 | 6,599 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $395,393 | 22,581 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||